News

A wave of diagnostic tests—some here, some coming—can identify cancer and Alzheimer’s at earlier stages and predict flare-ups ...
The test may make it easier to identify whether people with memory and thinking problems have Alzheimer’s or not.
Japan-based Fujirebio's test, which helps doctors diagnose Alzheimer's disease, is intended for patients with signs of ...
Since Alzheimer's disease affects over 7 million people in the U.S., potentially doubling to 14 million by 2050, earlier ...
The Lumipulse blood test identifies the presence of amyloid plaques, a hallmark of Alzheimer’s disease that impairs normal ...
The Lumipulse Alzheimer's blood test is the first of a new generation of tests that may replace brain scans and spinal taps to detect the disease.
The FDA has cleared the first blood test to diagnose Alzheimer's which works by measuring the amount of pTau 217 and ...
The FDA has cleared the first-ever blood test for early Alzheimer's detection, which the agency says reduces the need for ...
The FDA cleared marketing for the first in vitro diagnostic device that tests blood to aid in diagnosing Alzheimer disease.
The blood test measures two subtypes of tau and amyloid proteins, which can indicate the presence of amyloid plaque in the ...
The FDA said it has issued its first official green light for a blood test to help diagnose Alzheimer’s disease, adding that ...
The blood test is for patients 55 and older who have signs and symptoms of the mind-robbing disease. The Lumipulse blood plasma test detects a disease hallmark, amyloid plaques, which form in the ...